Towards safer surgery in patients with sickle cell disease

Saudi Medical Journal

Volumn 28, Issue 12, 2007, Pages 1788-1790

  Meshikhes, Abdul Wahed N ^a  

^a KING FAHAD SPECIALIST HOSPITAL   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ANALGESIC AGENT; ANTIBIOTIC AGENT; ARGININE; AZACITIDINE; FRUCTOSE 1,6 BISPHOSPHATE; HEMOGLOBIN F; HEMOGLOBIN S; HEPARIN; HYDROXYUREA; LOW MOLECULAR WEIGHT HEPARIN; NARCOTIC ANALGESIC AGENT; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; POLOXAMER;

ADJUVANT THERAPY; ANTIBIOTIC PROPHYLAXIS; BREATHING EXERCISE; ELECTIVE SURGERY; EPIDURAL ANESTHESIA; EXCHANGE BLOOD TRANSFUSION; GENERAL ANESTHESIA; HIGH RISK PATIENT; HUMAN; PATIENT CONTROLLED ANALGESIA; PEROPERATIVE CARE; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PAIN; PREOPERATIVE CARE; REVIEW; RISK REDUCTION; SICKLE CELL ANEMIA; SICKLE CELL CRISIS; SURGICAL MORTALITY; SURGICAL RISK; SURGICAL TECHNIQUE; THROMBOSIS; PERIOPERATIVE PERIOD;

ANEMIA, SICKLE CELL; HUMANS; PERIOPERATIVE CARE; PREOPERATIVE CARE;

EID: 41149158762     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Meshikhes AW, al-Faraj AA. Sickle cell disease and the general surgeon. J R Coll Surg Edin 1998; 43: 73-79.
2. Firth PG, Haed CA. Sickle cell disease and anesthesia. Anesthesiology 2004; 101: 766-785.
3. Claster S, Vichinsky EP. Managing sickle cell disease. BMJ 2003; 327: 1151-1155.
4. Serjeant GR. The emerging understanding of sickle cell disease. Br J Haematol 2001; 112: 3-18.
5. Vichinsky EP, Haberkern CM, Neumayr L, Earles AN, Black D, Koshy M, et al. A comparison of conservative and aggresive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group. N Engl J Med 1995; 27: 206-213.
6. Wali YA, al Okbi H, al Abri R. A comparison of two transfusion regimens in the perioperative management of children with sickle cell disease undergoing adenotonsillectomy. Pediatr Hematol Oncol 2003; 20: 7-13.
7. Al Salem AH, Qaiseruddin S, Naserulla Z. Perioperative management of children with sickle cell disease undergoing major abdominal surgery. Saudi Med J 2002; 23: 1294-1296.
8. Meshikhes AW. Preoperative management of children with sickle cell disease undergoing major abdominal surgery. Saudi Med J 2003; 24: 1033.
9. Meshikhes AW. Thromboprophylaxis in laparoscopic abdominal surgery. Annals of the College of Surgeons Hong Kong 2003; 7: 52-54.
10. Frietsch T, Ewen I, Waschke KF. Anaesthetic care for sickle cell disease. Eur J Anaesthesiol 2001; 18: 137-150.
11. Marchant W, Walker I. Anaesthetetic management of the child with sickle cell disease. Paediatr Anaesth 2003; 13: 473-489.
12. Meshikhes AW. Laparoscopic cholecystectomy in patients with sickle cell disease. Journal of the Irish College of Physicians and Surgeons 1995; 24: 91-92. Editoral
13. Ware RE, Kinney TR, Casey JR, Pappas TN, Meyers WC. Laparoscopic cholecystectomy in young patients wich sickle hemoglobinopathies. J Pediatr 1992; 120: 58-61.
14. Meshikhes AN, Al-Dhurais SA, Al-Jama A. Al-Faraj AA, Al-Khatir NS, Al-Abkari H. Laparoscopic cholecystectomy in patients with sickle cell disease. J R Coll Surg Edin 1995, 40. 383-385.
15. Meshikhes AW, Al-Abkari HA, Al-Faraj AA, Al-Dhurais SA, Al-Saif O. The safety of laparoscopic cholecystectomy in sickle cell disease: An update. Ann Saudi Med 1998; 18: 12-14.
16. Griffin TC, Buchanan GR. Elective surgery in children with sickle all disease without preoperative blood transfusion. J Pediatr Surg 1993; 28: 681-685.
17. Okpala I. Thomas V, Westerdale N, Jegede T, Raj K, Daley S, et al. The comprehensive care of sickle cell disease. Eur J Haematol 2O02; 68: 157-162.
18. Atweh GF, Loukapoulas D. Pharmacological induction of fetal hemoglobin in sickle cell disease and beta-thalassemia. Semin Hematol 2001; 38: 367-373.
19. Vichinsky E. New therapies in sickle cell disease. Lancet 2002; 360: 629-631.
20. Morris CR, Kuypers FA, Larkin S, Sweeters N, Simon J, Vichinsky EP, et al. Arginine therapy: A novel strategy to induce nitric oxide production in sickle cell disease. Br J Haematol 2000; 111: 498-500.
21. Dix HM. New advances in the treatment of sickle cell disease. focus on perioperative significance. AANA J 2001; 69: 281-286.
22. Walters MC, Storb R, Patience M, Leisenring W, Taylor T, Sanders JE, et al. Impact of bone marrow transplantation for symptomatic sickle cell disease: An interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease. Blood 2000; 95: 1918-1924.